GB

Gary E. L. Brandt

TI Theravance Biopharma R&D Ip: 4 patents #1 of 40Top 3%
📍 Alameda, CA: #13 of 202 inventorsTop 7%
🗺 California: #5,318 of 65,961 inventorsTop 9%
Overall (2022): #49,480 of 548,613Top 10%
4
Patents 2022

Issued Patents 2022

Showing 1–4 of 4 patents

Patent #TitleCo-InventorsDate
11453668 JAK inhibitors containing a 4-membered heterocyclic amide Paul R. Fatheree, Cameron Smith, Steven D. E. Sullivan, Lori Jean Van Orden 2022-09-27
11420965 Pyrimidine compound as JAK kinase inhibitor Jennifer Kozak, Ryan Hudson, Robert Murray McKinnell 2022-08-23
11299492 JAK kinase inhibitor compounds for treatment of respiratory disease Paul R. Fatheree, John R. Jacobsen, Melissa Fleury, Lan Jiang, Cameron Smith +3 more 2022-04-12
11254669 Fused imidazo-piperidine JAK inhibitors Paul R. Fatheree, Cameron Smith, Steven D. E. Sullivan, Lori Jean Van Orden 2022-02-22